Liam Morgan

Liam Morgan

Auto-generated profile, based on publicly available information

Liam Morgan

Welsh School of Pharmacy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2005 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
SHStephen Hiscox
Stephen Hiscox
LMLiam Morgan
Liam Morgan
TGTim P. Green
Tim P. Green
DBDenise Barrow
Denise Barrow
JGJulia Gee
Julia Gee
RNRobert I. Nicholson
Robert I. Nicholson

3 August 2005 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SHStephen Hiscox
Stephen Hiscox
Wen G. JiangWen G. Jiang
Wen G. Jiang
KOKathrin Obermeier
Kathrin Obermeier
KTKathryn Taylor
Kathryn Taylor
LMLiam Morgan
Liam Morgan
RNRobert I. Nicholson
Robert I. Nicholson
We have previously demonstrated that, following acquisition of endocrine resistance, breast cancer cells display an altered growth rate together with increased aggressive behaviour in vitro. Since dysfunctional cell–cell adhesive interactions can promote an aggressive phenotype, we investigated the integrity of this protein complex in our breast cancer model of tamoxifen resistance. In culture, tamoxifen-resistant MCF7 (TamR) cells grew as loosely packed colonies with loss of cell–cell junctions and demonstrated altered morphology characteristic of cells undergoing epithelial-to-mesenchymal transition (EMT). Neutralising E-cadherin function promoted the invasion and inhibited the aggregation of endocrine-sensitive MCF7 cells, whilst having little effect on the behaviour of TamR cells. Additionally, TamR cells had increased levels of tyrosine-phosphorylated β-catenin, whilst serine/threonine-phosphorylated β-catenin was decreased. These cells also displayed loss of association between β-catenin and E-cadherin, increased cytoplasmic and nuclear β-catenin and elevated transcription of β-catenin target genes known to be involved in tumour progression and EMT. Inhibition of EGFR kinase activity in TamR cells reduced β-catenin tyrosine phosphorylation, increased β-catenin–E-cadherin association and promoted cell–cell adhesion. In such treated cells, the association of β-catenin with Lef-1 and the transcription of c-myc, cyclin-D1, CD44 and COX-2 were also reduced. These results suggest that homotypic adhesion in tamoxifen-resistant breast cancer cells is dysfunctional due to EGFR-driven modulation of the phosphorylation status of β-catenin and may contribute to an enhanced aggressive phenotype and transition towards a mesenchymal phenotype in vitro.

1 October 2002 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MMMichael S. Morton
Michael S. Morton
OAOsamu Arisaka
Osamu Arisaka
NMNoriko Miyake
Noriko Miyake
LMLiam D. Morgan
Liam D. Morgan
BEBronwen Evans
Bronwen Evans
Asian individuals have much lower incidences of prostate and breast cancer than populations from Western developed countries. They also consume a lower fat, higher fiber diet, with a large intake of phytoestrogens. These phytoestrogens may protect against hormone-dependent cancers and other diseases. Our study used established gas chromatography-mass spectrometry (GC-MS) methodologies to measure the concentrations of four phytoestrogens (daidzein, genistein, equol and enterolactone) in serum samples obtained from Japanese men (n = 102) and women (n = 125) > 40 y old. The results were compared with those obtained with samples from the UK. The Japanese men and women had higher (P < 0.001) concentrations of circulating daidzein, genistein and equol than individuals from the UK. The mean concentration of genistein in Japanese men, for example, was 492.7 nmol/L, compared with 33.2 nmol/L in men from the UK. The two populations, however, had similar serum concentrations of enterolactone. Furthermore, 58% of the Japanese men and 38% of the Japanese women had equol concentrations > 20 nmol/L, compared with none of the UK men and 2.2% of the UK women. These results support previously published GC-MS results from studies with low numbers of samples.

1 May 2004 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
SHStephen Hiscox
Stephen Hiscox
LMLiam Morgan
Liam Morgan
DBDenise Barrow
Denise Barrow
CDCarol Dutkowski
Carol Dutkowski
AWAlan Wakeling
Alan Wakeling
RNRobert I. Nicholson
Robert I. Nicholson

21 May 2008 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
SHStephen Hiscox
Stephen Hiscox
NJN. J. Jordan
N. J. Jordan
CSC. Smith
C. Smith
MJM. James
M. James
LML. Morgan
L. Morgan
RNR. I. Nicholson
R. I. Nicholson

15 August 2009 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
LMLiam Morgan
Liam Morgan
JGJulia Gee
Julia Gee
SPSara Pumford
Sara Pumford
LFLynne Farrow
Lynne Farrow
PFPauline Finlay
Pauline Finlay
SHStephen Hiscox
Stephen Hiscox
Activated Src kinase may contribute to the progression and spread of breast cancers and recent in vitro evidence suggests a role for Src in acquired endocrine resistance. The purpose of this study ...